Study aimed to soothe rash from cancer drugs, but never started
Symptom relief
Terminated
This study was designed to see if a cream called ATR-04 could safely reduce a common, painful rash on the face caused by certain cancer drugs. It planned to include about 60 adults with cancer who were about to start those drugs. However, the study was withdrawn before any partic…
Phase: PHASE1, PHASE2 • Sponsor: Azitra Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC